Noom Medical
Behavior-change weight-loss platform with Noom Med / GLP-1 Rx programs, clinician access, habit-change tools, community features, and medication support integrated into the Noom app.
Access model
Primarily D2C; supports both insurance and cash-pay medication pathways
Editorial note
Noom has one of the deepest public research libraries among digital weight-loss platforms.
Coverage and cost
Yes/varies; Noom supports both insured and uninsured users
Noom Med marketed from $149; microdose GLP-1 Rx from $99; some clinician-only plans start at $69 excluding branded medication cost
Yes; Noom publicly markets compounded GLP-1 / microdose GLP-1 Rx options alongside brand-name meds
Market signals
Evidence and positioning
Noom Med claims users lose 48% more weight in 6 months vs GLP-1s without Noom. Noom research/publications page also cites 75% of individuals maintaining ≥5% weight loss at 1 year and 49% maintaining 10%.
This is the lower dB's current read on Noom Medical's pricing posture, insurance story, medication posture, and evidence signaling.
Source References
6 public references used in this profile. Links open in a new tab for quick verification.
Pricing, insurance coverage, medication availability, and eligibility can change quickly. Verify current details directly with the provider before starting or switching care.